DISPATCHES FROM THE BIOLOGICAL PRODUCTION FORUM, DUBLIN
Pfizer stays stainless saying single-use cost burdens high volume production
Single-use technology for high volume biomanufacturing is riddled with problems and will only be fully implemented by industry once the cost drops, according to Pfizer.